223 related articles for article (PubMed ID: 34597878)
1. GSK-3β as a target for apigenin-induced neuroprotection against Aβ 25-35 in a rat model of Alzheimer's disease.
Alsadat AM; Nikbakht F; Hossein Nia H; Golab F; Khadem Y; Barati M; Vazifekhah S
Neuropeptides; 2021 Dec; 90():102200. PubMed ID: 34597878
[TBL] [Abstract][Full Text] [Related]
2. BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.
Yu CJ; Liu W; Chen HY; Wang L; Zhang ZR
Cell Biochem Funct; 2014 Oct; 32(7):590-6. PubMed ID: 25230339
[TBL] [Abstract][Full Text] [Related]
3. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
5. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
6. Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.
Lahmy V; Meunier J; Malmström S; Naert G; Givalois L; Kim SH; Villard V; Vamvakides A; Maurice T
Neuropsychopharmacology; 2013 Aug; 38(9):1706-23. PubMed ID: 23493042
[TBL] [Abstract][Full Text] [Related]
7. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576.
Chauhan NB; Siegel GJ; Feinstein DL
Neuropharmacology; 2005 Jan; 48(1):93-104. PubMed ID: 15617731
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
Koh SH; Noh MY; Kim SH
Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats.
Nan S; Wang P; Zhang Y; Fan J
Drug Des Devel Ther; 2021; 15():2013-2024. PubMed ID: 34012254
[TBL] [Abstract][Full Text] [Related]
10. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.
Zhao R; Zhang Z; Song Y; Wang D; Qi J; Wen S
J Ethnopharmacol; 2011 Feb; 133(3):1109-16. PubMed ID: 21129477
[TBL] [Abstract][Full Text] [Related]
11. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo.
Kim HG; Park G; Lim S; Park H; Choi JG; Jeong HU; Kang MS; Lee MK; Oh MS
J Ethnopharmacol; 2015 Aug; 171():196-204. PubMed ID: 26068423
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation.
Hoppe JB; Frozza RL; Horn AP; Comiran RA; Bernardi A; Campos MM; Battastini AMO; Salbego C
J Pineal Res; 2010 Apr; 48(3):230-238. PubMed ID: 20136701
[TBL] [Abstract][Full Text] [Related]
13. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
14. Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer's disease-like neuropathology and cognitive deficits.
Lei L; Luo Y; Kang D; Yang F; Meng D; Wang JZ; Liu R; Wang X; Li HL
Aging (Albany NY); 2023 Dec; 15(23):14172-14191. PubMed ID: 38095632
[TBL] [Abstract][Full Text] [Related]
15. Naringin Protects against Tau Hyperphosphorylation in A
Qiu Q; Lei X; Wang Y; Xiong H; Xu Y; Sun H; Xu H; Zhang N
Behav Neurol; 2023; 2023():1857330. PubMed ID: 36844418
[TBL] [Abstract][Full Text] [Related]
16. Design and Synthesis of New Benzo[d]oxazole-Based Derivatives and Their Neuroprotective Effects on β-Amyloid-Induced PC12 Cells.
Liu Z; Bian M; Ma QQ; Zhang Z; Du HH; Wei CX
Molecules; 2020 Nov; 25(22):. PubMed ID: 33218007
[TBL] [Abstract][Full Text] [Related]
17. [Study of the protection and mechanism of IGF-1 on tau protein hyperphosphorylation in PC12 cells induced by Abeta(1-40)].
Wang PJ; Zhang Y; Song RR; Shen DF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):960-4. PubMed ID: 21265094
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
19. The Neuroprotective Effects of Justicidin A on Amyloid Beta25-35-Induced Neuronal Cell Death Through Inhibition of Tau Hyperphosphorylation and Induction of Autophagy in SH-SY5Y Cells.
Gu MY; Kim J; Yang HO
Neurochem Res; 2016 Jun; 41(6):1458-67. PubMed ID: 26887582
[TBL] [Abstract][Full Text] [Related]
20. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.
Phiel CJ; Wilson CA; Lee VM; Klein PS
Nature; 2003 May; 423(6938):435-9. PubMed ID: 12761548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
